UA84696C2 - Лечение бактериальных заболеваний органов дыхания путем местного применения фторхинолонов - Google Patents

Лечение бактериальных заболеваний органов дыхания путем местного применения фторхинолонов

Info

Publication number
UA84696C2
UA84696C2 UAA200508641A UA2005008641A UA84696C2 UA 84696 C2 UA84696 C2 UA 84696C2 UA A200508641 A UAA200508641 A UA A200508641A UA 2005008641 A UA2005008641 A UA 2005008641A UA 84696 C2 UA84696 C2 UA 84696C2
Authority
UA
Ukraine
Prior art keywords
fluoroquinolones
treatment
respiratory organs
bacterial diseases
locally applying
Prior art date
Application number
UAA200508641A
Other languages
English (en)
Ukrainian (uk)
Inventor
Харальд Лабишински
Кристоф Ладель
Уве Петерсен
Бен НЬЮТОН
Original Assignee
Байер Хэлскер Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Хэлскер Аг filed Critical Байер Хэлскер Аг
Publication of UA84696C2 publication Critical patent/UA84696C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение касается применения лекарственных препаратов на основе производных хинолонкарбоновой кислоты в виде твердого бетаина и/или твердой сложно растворимой бетаиновой соли, предназначенных для местного лечения заболеваний органов дыхания, в частности легочных заболеваний.
UAA200508641A 2003-02-10 2004-01-28 Лечение бактериальных заболеваний органов дыхания путем местного применения фторхинолонов UA84696C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10305318A DE10305318A1 (de) 2003-02-10 2003-02-10 Behandlung bakteriell verursachter Lungenkrankheiten

Publications (1)

Publication Number Publication Date
UA84696C2 true UA84696C2 (ru) 2008-11-25

Family

ID=32730929

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200508641A UA84696C2 (ru) 2003-02-10 2004-01-28 Лечение бактериальных заболеваний органов дыхания путем местного применения фторхинолонов

Country Status (3)

Country Link
DE (1) DE10305318A1 (ru)
ES (1) ES2352729T3 (ru)
UA (1) UA84696C2 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009140587A1 (en) * 2008-05-15 2009-11-19 Novartis Ag Pulmonary delivery of a fluoroquinolone

Also Published As

Publication number Publication date
ES2352729T3 (es) 2011-02-22
DE10305318A1 (de) 2004-08-19

Similar Documents

Publication Publication Date Title
CY1118137T1 (el) Αερολυμενες φθοροκινολονες και χρησεις αυτων
DE60318193D1 (en) Phenethanolaminderivate
PH12012501421A1 (en) Voltage-gated sodium channel blockers
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
CY1110998T1 (el) Θεραπεια βακτηριακων ασθενειων των αναπνευστικων οργανων με τοπικη εφαρμογη φθοροκινολονων
UA93872C2 (ru) Дигидротиенопиримидины для лечения воспалительных заболеваний
MY177111A (en) Substituted amide derivatives and methods of use
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
MX2008016134A (es) Derivados de fenol para el tratamiento de enfermedades respiratorias.
MX2010001236A (es) Derivados de 5-fenil-isoxazol-3-carboxamida como moduladores del receptor de potencial transitorio v1 (trpv1).
MX2009008531A (es) Cetonas de heterociclilo que contienen nitrogeno y su uso como inhibidores de c-met.
MY140826A (en) Substituted pyrazoline compounds, their preparation and use as medicaments.
MY142029A (en) Phenoxyacetic acid derivatives
MX2009000531A (es) Derivados heterociclicos fusionados y metodos de uso.
MX2010002498A (es) Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol.
EA201001747A1 (ru) Бензоксазиноновые производные, действующие в качестве агониста бета-2-адренорецептора, для лечения респираторных расстройств
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
TW200635597A (en) Substituted pteridines for the treatment of inflammatory diseases
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
WO2006081431A3 (en) Compounds for treating inflammatory and demyelinating diseases
MX2009013482A (es) Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas.
WO2007009724A3 (en) Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments
MX2007006357A (es) Pteridinas sustituidas para el tratamiento de enfermedades inflamatorias.
MXPA05010161A (es) Combinacion sinergistica que comprende roflumilast y un agente anticolinergico seleccionado a partir de sales de ipratropio, oxitropio y tiotropio para el tratamiento de enfermedades respiratorias.
EP4620940A3 (en) Synthesis of (+)-cannabinoids and their therapeutic effects